
Biogen has announced it has inked an agreement to acquire clinical-stage gene therapy firm Nightstar for a total value of …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

